Top MarketRank™ StocksTop MarketRank™NYSE:HUM Humana (HUM) Stock Price, News & Analysis $243.20 +6.91 (+2.92%) (As of 10/8/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Humana Stock (NYSE:HUM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Humana alerts:Sign Up Key Stats Today's Range$240.00▼$246.7150-Day Range$236.27▼$404.5252-Week Range$213.31▼$530.54Volume3.20 million shsAverage Volume1.80 million shsMarket Capitalization$29.31 billionP/E Ratio15.14Dividend Yield1.46%Price Target$324.86Consensus RatingHold Company OverviewHumana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More… [SHOCKING] Crypto Document Leak… (Ad)The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.Download your digital copy now Humana Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks100th Percentile Overall ScoreHUM MarketRank™: Humana scored higher than 100% of companies evaluated by MarketBeat, and ranked 7th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingHumana has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on 6 buy ratings, 17 hold ratings, and 1 sell rating.Amount of Analyst CoverageHumana has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth22.99% Earnings GrowthEarnings for Humana are expected to grow by 22.99% in the coming year, from $16.01 to $19.69 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 15.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.10.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 15.14, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 126.30.Price to Earnings Growth RatioHumana has a PEG Ratio of 2.44. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.87% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently increased by 6.16%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldHumana pays a meaningful dividend of 1.27%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 22.04%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 17.98% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. Sustainability and ESG3.9 / 5Environmental Score-0.75 Percentage of Shares Shorted1.87% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently increased by 6.16%, indicating that investor sentiment is decreasing significantly. News and Social Media2.1 / 5News Sentiment-0.14 News SentimentHumana has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 77 news articles for Humana this week, compared to 21 articles on an average week.Search Interest55 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 293% compared to the previous 30 days.MarketBeat Follows12 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.32% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. Receive HUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter. Email Address HUM Stock News Headlines3 Oversold Stocks with Big RSI Rebound Potential (HUM)Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. The RSI indicator is a great way to find them.October 3, 2024 | marketbeat.comQuality ratings hit to key Medicare plan shakes Humana stockShares of Humana tumbled early Wednesday after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus payments the company receivesOctober 2, 2024 | marketbeat.com[SHOCKING] Crypto Document Leak…The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.October 8, 2024 | Crypto 101 Media (Ad)Here’s Why Surgery Partners Could Be the Next Hot Takeover (HUM)Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations.September 25, 2024 | marketbeat.comVerint Systems' AI Bots Revolutionize Customer Service Efficiency (HUM)Verint's AI bots help automate customer service, cutting call times and improving efficiency, making it a key player in AI-driven customer experience solutions.September 11, 2024 | marketbeat.comSpotlight on Humana: Analyzing the Surge in Options ActivityOctober 8 at 2:43 PM | benzinga.comHumana ends selloff as Bernstein upgrades on attractive entry pointOctober 8 at 2:43 PM | msn.comHumana Gets an Upgrade. Why an Analyst Says the Beaten-Down Stock Is a Buy.October 8 at 1:23 PM | barrons.comSee More Headlines HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $457.81 at the start of the year. Since then, HUM stock has decreased by 46.9% and is now trading at $243.20. View the best growth stocks for 2024 here. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) released its quarterly earnings data on Wednesday, July, 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.89 by $1.07. The business's revenue was up 10.4% on a year-over-year basis. Read the conference call transcript. Does Humana have any subsidiaries? Humana subsidiaries include these companies: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and more. Who are Humana's major shareholders? Top institutional investors of Humana include AMF Tjanstepension AB (0.03%), Handelsbanken Fonder AB (0.03%), Czech National Bank (0.02%) and Czech National Bank (0.02%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Samir Deshpande, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA) and Boeing (BA). Company Calendar Ex-Dividend for 7/26 Dividend6/28/2024Dividend Payable7/26/2024Last Earnings7/31/2024Ex-Dividend for 10/25 Dividend9/30/2024Today10/08/2024Dividend Payable10/25/2024Next Earnings (Confirmed)10/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:HUM CUSIP44485910 CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,600Year Founded1961Price Target and Rating Average Stock Price Target$324.86 High Stock Price Target$550.00 Low Stock Price Target$247.00 Potential Upside/Downside+33.6%Consensus RatingHold Rating Score (0-4)2.21 Research Coverage24 Analysts Profitability EPS (Most Recent Fiscal Year)$16.06 Trailing P/E Ratio15.14 Forward P/E Ratio15.19 P/E Growth2.44Net Income$2.49 billion Net Margins1.53% Pretax Margin2.18% Return on Equity16.12% Return on Assets5.26% Debt Debt-to-Equity Ratio0.70 Current Ratio1.66 Quick Ratio1.66 Sales & Book Value Annual Sales$112.04 billion Price / Sales0.26 Cash Flow$26.64 per share Price / Cash Flow9.13 Book Value$132.55 per share Price / Book1.83Miscellaneous Outstanding Shares120,501,000Free Float120,115,000Market Cap$29.31 billion OptionableOptionable Beta0.50 Social Links Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (NYSE:HUM) was last updated on 10/8/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
